Quick Answer
Kairos Pharma, LTD. reported Total Assets of $6.54 million for the year ending 2025.
- Kairos Pharma, LTD. showed an increase of +13.4% in Total Assets from 2024 to 2025.
- This data is from Kairos Pharma, LTD.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $5.00 million | Q1 2025: $7.94 million | Q2 2025: $6.67 million | Q3 2025: $8.07 million.
- Over the full 3 years of available data (2023 to 2025), Kairos Pharma, LTD.'s Total Assets has grown by 577.7%.
- Historical annual values: Fiscal year 2025: $6.54 million | Fiscal year 2024: $5.77 million | Fiscal year 2023: $965.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: